We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 127

No Love Lost for FDA Over Granola Ingredients
  • Manatt Phelps & Phillips LLP
  • USA
  • October 26 2017

The Food and Drug Administration showed no love for Nashoba Brook Bakery’s granola by sending a letter to the Massachusetts business instructing it to


Weight Loss Drug Gains FDA Warning About False Advertising
  • Manatt Phelps & Phillips LLP
  • USA
  • June 15 2017

In the first warning letter sent since President Donald J. Trump took office, the Food and Drug Administration (FDA) cautioned the maker of a weight


The Goldilocks Theory of Bringing Change to the FDA
  • Manatt Phelps & Phillips LLP
  • USA
  • May 24 2017

The nomination of Dr. Scott Gottliebwho has now been confirmed to lead the Food and Drug Administration (FDA)drove another Goldilocks debate. Like


Faxed Dinner Invite May Violate TCPA, Second Circuit Rules
  • Manatt Phelps & Phillips LLP
  • USA
  • March 21 2017

The U.S. Court of Appeals for the Second Circuit handed a loss to a pharmaceutical company in a Telephone Consumer Protection Act action, reversing


Regulatory Concerns Around Big Data, Artificial Intelligence and the IoT
  • Manatt Phelps & Phillips LLP
  • USA
  • January 23 2017

Data is everywhere. By some estimates, 90 of the world's data has been created in the last two years. This deluge is only going to intensify as the


FDA Releases Interim Guidance on “Healthy” Labeling
  • Manatt Phelps & Phillips LLP
  • USA
  • October 14 2016

New interim guidance from the Food and Drug Administration eased the restrictions on foods that can be labeled as "healthy," and provides insight as


Agreement Reached on Bipartisan Federal GMO Food Labeling Bill
  • Manatt Phelps & Phillips LLP
  • USA
  • June 30 2016

Senate Agriculture Committee leaders reached agreement June 23, 2016, on a bill that would require food containing genetic material modified by


Regulators Continue to Look Closely at Medical Device Cybersecurity (and Maybe Congress, Too)
  • Manatt Phelps & Phillips LLP
  • USA
  • March 23 2016

On February 5, 2016, U.S. Senator Barbara Boxer of California sent a letter to five of the country's largest medical device manufacturers, expressing


Challenge to Handmade Vodka Moves Forward in New York
  • Manatt Phelps & Phillips LLP
  • USA
  • March 17 2016

A reasonable consumer could be misled by the label on Tito's Handmade Vodka, a New York federal court judge ruled in denying the manufacturer's motion


FDA to Study Animation in Drug Ads
  • Manatt Phelps & Phillips LLP
  • USA
  • March 16 2016

The Food and Drug Administration will consider the use of animation in drug ads, the agency announced, and whether such commercials might improperly